Shane Burgess is the founder of Treadwell Therapeutics. Treadwell Therapeutics has raised $118M in total funding. Latest round: Series B.
Shane Burgess is the Co-CEO of Treadwell Therapeutics, a clinical-stage oncology company focused on developing novel cross-modality medicines for cancer patients. The company was launched by TIO Bioventures with an initial $27 million seed round in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library